Corcept Therapeutics Incorporated · NASDAQ:CORT

Lyon Joseph Douglas received 260 Corcept Therapeutics Incorporated shares as an award (Form 4)

Traded Sep 1 to Sep 2, 2026 · Filed Sep 3, 2026

From Sep 1 to Sep 2, 2026, Lyon Joseph Douglas (See Remarks) received 260 Corcept Therapeutics Incorporated shares as an award at US$113.38 for US$14,739, leaving 5,683 shares. Filed Sep 3, 2026 (Form 4).

Awarded
260 shares
Price
US$113.38
Value
US$14,739
Holding after
5,683 shares
Trading plan
No
Role
See Remarks

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 1, 2026Common StockAward130US$113.385,625Direct
Sep 1, 2026Common StockAward1305,755Direct
Sep 2, 2026Common StockShares withheld for tax72US$113.385,683Direct

Source

View original at SEC

Related